Furthermore, pain-mediated neuronal signaling and neuroinflammation were ameliorated by CX3CL1 neutralizing Ab administration in multiple sclerosis and hepatic encephalopathy models [60, 78]. Here, CX3CL1 is linked to multiple sclerosis.